MYR Pharmaceuticals Logo (WIPO, 10/26/2020)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark MYR Pharmaceuticals was filed as Figurative mark on 10/26/2020 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Triangles, lines forming an angle #Letters presenting a special form of writing #Colours #One triangle #Triangular figures with one or more truncated or rounded angles #Triangles containing one or more letters #Series of letters in different dimensions #Series of letters separated from one another other than by a single space #Three predominant colours
| Trademark form | Figurative mark |
| File reference | 1591282 |
| Register number | 302020105510 |
| Countries | 
|
| Base trademark |
No. 30 2020 105 510,
August 17, 2020
|
| Application date | October 26, 2020 |
| Expiration date | October 26, 2030 |
Trademark owner
Burgwedel,
Fraunhoferstr. 17
DE
Fraunhoferstr. 17
DE
Trademark representatives
Attn: Gretchen R. Stroud,
333 Lakeside Drive
US
goods and services
01
Chemicals for use in industry and science; peptides
substrates for scientific and industrial purposes;
oligopeptides; polypeptides; proteins [raw material];
polynucleotides [chemicals for scientific purposes];
oligonucleotides [chemicals for scientific purposes];
nucleic acids; SiRNA molecules; small molecules having a
molar mass of 160 to 480 [for scientific purposes]
05
Pharmaceutical and veterinary preparations; biological
preparations for medical purposes; biological preparations
for veterinary purposes; biochemical preparations for
medical purposes; biochemical preparations for veterinary
purposes; chemical preparations for medical purposes;
chemical preparations for veterinary purposes; medicines for
medical purposes; medicines for veterinary purposes;
pharmaceutical preparations for treating liver diseases and
disorders; pharmaceutical products for hepatitis B;
pharmaceutical products for hepatitis D; pharmaceutical
preparations for dyslipidemia; pharmaceutical preparations
for nonalcoholic steatohepatitis [NASH]; pharmaceutical
preparations for primary biliary cholangitis [PBC];
pharmaceutical preparations for inflammatory diseases;
pharmaceutical preparations for inflammatory diseases
inhibiting sodium-taurocholate co-transporting polypeptide
[NTCP]; pharmaceutical preparations for the treatment of
metabolic diseases; pharmaceutical preparations for the
treatment of metabolic diseases inhibiting
sodium-taurocholate co-transporting polypeptide [NTCP]
09
Scientific, surveying, weighing, measuring apparatus and
instruments; apparatus and instruments for scientific
research, in particular scientific research in laboratories;
data processing apparatus; computers; CDs; DVDs; digital
recording media; computer software
42
Scientific and technological services and research and
design relating thereto; industrial analysis services;
industrial research services; scientific research for
medical, chemical, biological, veterinary and pharmaceutical
purposes; scientific and technological services and research
and design related thereto in the field of hepatitis B;
scientific and technological services and research and
design related thereto in the field of hepatitis D;
scientific and technological services and research and
design related thereto in the field of dyslipidemia;
scientific and technological services and research and
design related thereto in the field of nonalcoholic
steatohepatitis [NASH]; scientific and technological
services and research and design related thereto in the
field of primary biliary cholangitis [PBC]; scientific and
technological services and research and design related
thereto in the field of inflammatory diseases; scientific
and technological services and research and design related
thereto in the field of inflammatory diseases inhibiting
sodium-taurocholate co-transporting polypeptide [NTCP];
scientific and technological services and research and
design related thereto in the field of metabolic diseases;
scientific and technological services and research and
design related thereto in the field of metabolic diseases
inhibiting sodium-taurocholate co-transporting polypeptide
[NTCP]; design and development of computer hardware and
software; scientific and technological services in the field
of preclinical development, in particular related to
hepatitis B, hepatitis D, dyslipidemia, nonalcoholic
steatohepatitis [NASH], inflammatory diseases, inflammatory
diseases inhibiting sodium-taurocholate co-transporting
polypeptide [NTCP], primary biliary cholangitis [PBC],
metabolic diseases, and metabolic diseases inhibiting
sodium-taurocholate co-transporting polypeptide [NTCP];
scientific and technological services in the field of
clinical development, in particular related to hepatitis B,
hepatitis D, dyslipidemia, nonalcoholic steatohepatitis
[NASH], primary biliary cholangitis [PBC], inflammatory
diseases, inflammatory diseases inhibiting
sodium-taurocholate co-transporting polypeptide [NTCP],
metabolic diseases, and metabolic diseases inhibiting
sodium-taurocholate co-transporting polypeptide [MVP]
44
Medical services; veterinary services; medical and
veterinary services, in particular medical analysis in
connection with the treatment of individuals; providing
information in the medical field, veterinary field and
pharmacology; services of health centres; services of
clinics (ambulances); therapy services; hygienic and beauty
care for human beings and animals
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| June 20, 2023 | 2023/25 Gaz | PH | Rejection |
| February 22, 2023 | 2023/11 Gaz | KH | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| December 30, 2022 | 2023/6 Gaz | AM | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| November 29, 2022 | 2022/48 Gaz | NZ | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| November 19, 2022 | 2022/48 Gaz | UZ | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| November 9, 2022 | 2022/45 Gaz | TH | Rejection |
| November 7, 2022 | 2022/47 Gaz | CU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| October 31, 2022 | 2022/44 Gaz | WS | Rejection |
| October 26, 2022 | 2022/43 Gaz | IS | Rejection |
| October 25, 2022 | 2022/44 Gaz | AL | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| October 19, 2022 | 2022/42 Gaz | TM | Rejection |
| October 14, 2022 | 2022/43 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| September 17, 2022 | 2022/39 Gaz | RAW: Limitation | |
| September 14, 2022 | 2022/39 Gaz | KH | Rejection |
| August 30, 2022 | 2022/39 Gaz | MD | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| August 26, 2022 | 2022/39 Gaz | TJ | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| August 25, 2022 | 2022/35 Gaz | BA | Rejection |
| August 25, 2022 | 2022/36 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| August 24, 2022 | 2022/34 Gaz | CA | Rejection |
| August 10, 2022 | 2022/32 Gaz | ID | Rejection |
| August 8, 2022 | 2022/35 Gaz | PH | Rejection |
| July 27, 2022 | 2022/34 Gaz | RAW: Limitation | |
| July 4, 2022 | 2022/31 Gaz | IL | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| July 1, 2022 | 2022/28 Gaz | KZ | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| July 1, 2022 | 2022/26 Gaz | MX | Rejection |
| June 14, 2022 | 2022/27 Gaz | GE | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| June 2, 2022 | 2022/23 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| May 31, 2022 | 2022/22 Gaz | LA | Rejection |
| May 25, 2022 | 2022/22 Gaz | MY | Rejection |
| May 20, 2022 | 2022/28 Gaz | KP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| May 17, 2022 | 2022/22 Gaz | UZ | Rejection |
| May 12, 2022 | 2022/23 Gaz | AL | Rejection |
| May 11, 2022 | 2022/19 Gaz | LI | Rejection |
| May 11, 2022 | 2022/20 Gaz | VN | Rejection |
| May 6, 2022 | 2022/20 Gaz | AM | Rejection |
| April 28, 2022 | 2022/19 Gaz | CU | Rejection |
| April 25, 2022 | 2022/17 Gaz | RU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| April 20, 2022 | 2022/21 Gaz | MN | Rejection |
| April 12, 2022 | 2022/15 Gaz | CH | Rejection |
| April 11, 2022 | 2022/15 Gaz | OA | Rejection |
| April 6, 2022 | 2022/17 Gaz | BW | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| April 1, 2022 | 2022/15 Gaz | TJ | Rejection |
| March 25, 2022 | 2022/13 Gaz | ME | Rejection |
| March 25, 2022 | 2022/13 Gaz | MD | Rejection |
| March 23, 2022 | 2022/14 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| March 22, 2022 | 2022/12 Gaz | NO | Rejection |
| March 13, 2022 | 2022/11 Gaz | UA | Rejection |
| March 5, 2022 | 2022/11 Gaz | AZ | Rejection |
| March 3, 2022 | 2022/9 Gaz | JP | Rejection |
| February 28, 2022 | 2022/9 Gaz | KR | Rejection |
| February 24, 2022 | 2022/9 Gaz | BN | Rejection |
| February 18, 2022 | 2022/9 Gaz | KZ | Rejection |
| February 17, 2022 | 2022/8 Gaz | GE | Rejection |
| February 15, 2022 | 2022/7 Gaz | SX | Rejection |
| January 28, 2022 | 2022/5 Gaz | KG | Rejection |
| January 20, 2022 | 2022/11 Gaz | MG | Rejection |
| January 20, 2022 | 2022/3 Gaz | CO | Rejection |
| December 29, 2021 | 2021/52 Gaz | GB | Rejection |
| December 20, 2021 | 2021/51 Gaz | CW | Rejection |
| December 6, 2021 | 2021/49 Gaz | DZ | Rejection |
| December 3, 2021 | 2021/49 Gaz | MC | Rejection |
| November 23, 2021 | 2021/47 Gaz | BR | Rejection |
| November 18, 2021 | 2021/46 Gaz | BT | Rejection |
| November 18, 2021 | 2021/46 Gaz | SY | Rejection |
| November 17, 2021 | 2021/46 Gaz | SM | Rejection |
| November 12, 2021 | 2021/47 Gaz | KP | Rejection |
| November 10, 2021 | 2021/45 Gaz | BY | Rejection |
| November 9, 2021 | 2021/45 Gaz | RS | Rejection |
| October 22, 2021 | 2021/44 Gaz | NA | Rejection |
| October 20, 2021 | 2021/42 Gaz | TR | Rejection |
| October 6, 2021 | 2021/40 Gaz | EM | Rejection |
| September 30, 2021 | 2021/40 Gaz | MN | Rejection |
| September 29, 2021 | 2021/40 Gaz | IL | Rejection |
| September 7, 2021 | 2021/39 Gaz | CN | Rejection |
| September 6, 2021 | 2021/37 Gaz | RU | Rejection |
| August 20, 2021 | 2021/34 Gaz | NZ | Rejection |
| August 12, 2021 | 2021/35 Gaz | BW | Rejection |
| July 29, 2021 | 2021/30 Gaz | AU | Rejection |
| July 23, 2021 | 2021/30 Gaz | SG | Rejection |
| June 30, 2021 | 2021/37 Gaz | RAW: Limitation | |
| May 31, 2021 | 2021/23 Gaz | IN | Rejection |
| May 24, 2021 | 2021/22 Gaz | US | Rejection |
| May 23, 2021 | 2021/22 Gaz | PH | Rejection |
| October 26, 2020 | 2021/17 Gaz | DE | Registration |
ID: 141591282